Results 31 to 40 of about 735 (140)

Molnupiravir in the treatment of patients with influenza or acute respiratory viral infections: a multicenter comparative randomized double-blind placebo-controlled trial

Фармация и фармакология (Пятигорск)
The aim. To evaluate the efficacy and safety of molnupiravir compared to placebo in patients with influenza and/or ARVI.Materials and methods. The study involved 300 patients.
O. M. Drapkina, A. Yu. Gorshkov, T I. Chudinovskikh, E. N. Simakina, G. V. Rodoman, V. V. Popova, I. V. Balaban, L. A. Balykova, N. M. Selezneva, N. V. Kirichenko, R. S. Kozlov, D. A. Bystritskii, V. B. Vasilyuk, K. Ya. Zaslavskaya, P. A. Bely, K. N. Koryanova, E. S. Mishchenko, A. V. Taganov, L. A. Pochaevets, V. S. Scherbakova   +19 more
doaj   +1 more source

Pharmacological and non-pharmacological treatments for ARVI

Медицинский совет, 2015
ARVI is one of the most common diseases worldwide. Search for adequate treatment remains an urgent public healthcare problem globally. The main task is still an effective and safe relief of ARVI symptoms, for the purpose of which both pharmacological and
I. L. Lazarevich
doaj   +1 more source

Повторные бактериальные осложнения ОРВИ у детей: этиологические аспекты и современные подходы к терапии [PDF]

, 2016
В статье рассмотрены вопросы повторных бактериальных осложнений ОРВИ в детском возрасте. Изучалась микробиологическая структура осложнений, а также изучены уровни лактоферрина, лизоцима, секреторного иммуноглобулина А, человеческого кателицидина в ...
Карпенко, А.В., Шварацкая, О.В.   +1 more
core   +1 more source

ЭПИДЕМИОЛОГИЧЕСКАЯ ОЦЕНКА ЗАБОЛЕВАЕМОСТИ ОРВИ В ДЕТСКОМ МНОГОПРОФИЛЬНОМ СТАЦИОНАРЕ [PDF]

, 2018
The results of the evaluation of the incidence of acute respiratory viral infection (ARVI) in a large children's multidisciplinary hospital are presented.It was established that the epidemic process of ARVI in the conditions of a children's versatile ...
L. V. Poslova, Д. В. Квашнина, D. V. Kvashnina, Л. Ю. Послова, А. В. Сергеева, O. V. Kovalishena, A. V. Sergeeva, О. В. Ковалишена   +7 more
core   +2 more sources

An open, observational, non-interventional, multicenter study of the effect of Kagocel® on the quality of life of patients with acute respiratory viral infections in realworld clinical practice in the Republic of Kazakhstan

Реальная клиническая практика: данные и доказательства
Relevance. Acute respiratory infections are the leading cause of disease worldwide. Kagocel® is a synthetic antiviral agent indicated for influenza and other acute respiratory viral infections (ARVI).
B. N. Kosherova, S. A. Kulzhanova, A. K. Duisenova, E. S. Zhunusov, G. N. Abuova   +4 more
doaj   +1 more source

Mucolytic therapy of ARD in pregnant women

Медицинский совет, 2013
Acute respiratory disease (ARD) is one of the most common pathologies in pregnant women. During their pregnancy, about 2/3 of women suffer from one or several episodes of ARD of any severity.
R. A. Bontsevich, O. V. Golovchenko
doaj   +1 more source

Assessment of Population Immunity to Influenza and Acute Respiratory Viral Infections of Moscow Population during 2023–2024 Epidemic Season

Эпидемиология и вакцинопрофилактика
Relevance. Acute respiratory viral infections (ARVI) annually occupy leading positions in terms of morbidity and economic damage both in the world and in the Russian Federation. From an epidemiological point of view, it is important to constantly monitor
V. A. Gushchin, T. A. Semenenko, E. I. Burtseva, Y. V. Simakova, D. A. Ogarkova, A. V. Nozdracheva, T. P. Gotvyanskaya, T. V. Ermakova, E. N. Vetrova, E. А. Mukasheva, T. I. Subbotina   +10 more
doaj   +1 more source

The role of combination drugs in etiopathogenetic pharmacotherapy of acute respiratory viral infections

Медицинский совет, 2014
The article considers current issues of the pathogenesis of acute respiratory viral infections (ARVI); there is current data on the advantages and disadvantages of the main groups of drugs used in the pharmacotherapy of ARVI.
O. A. Mubarakshina
doaj   +1 more source

Клинико-лабораторные особенности госпитализируемых пациентов с ОРВИ

, 2017
моно и микст формы ОРВИ, клинические ...
Прокопова, А. Ю., Жолик, А. Ю., Жолик, Г. Ю.   +2 more
core   +1 more source

Prospects for Expanding the Possibilities of Etiotropic Therapy of Acute Respiratory Viral Infections in Primary School Children

Антибиотики и Химиотерапия
The aim of the study was to evaluate the efficacy and safety of the drug riamilovir (Triazavirin®), 100 mg capsules, in children aged 6–11 years with a diagnosis of acute respiratory viral infection (ARVI).   Materials and methods.
K. V. Zhdanov, Yu. V. Lobzin, A. U. Sabitov, E. V. Esaulenko, P. V. Sorokin   +4 more
doaj   +1 more source